A growing body of evidence has shown that the cGAS-STING pathway was also activated by host DNA, which aberrantly localized in the cytosol, contributing to increased sterile inflammation, insulin resistance, and the development of NAFLD (Isfort et al. 2014; Luo et al. 2018). Here, CGAS is linked to metabolic dysfunction-associated steatotic liver disease.